Hepatitis C virus antibodies in high-risk Saudi groups
- PMID: 1907415
- DOI: 10.1111/j.1423-0410.1991.tb00894.x
Hepatitis C virus antibodies in high-risk Saudi groups
Abstract
The recombinant-based enzyme immunoassay developed by Ortho Diagnostic System for the detection of antibodies of hepatis C virus (HCV) was used to determine the extent of exposure to HCV in healthy Saudi subjects (500 males; 260 females) without liver disease and with no history of percutaneous exposure to blood and in Saudis who are considered at high risk for contracting the disease: hemophiliacs (28), thalassemics (78), hemodialysis patients with renal failure (65) and patients with sexually transmitted diseases (STD) (220). The results show that HCV is endemic in the Saudi population with an overall frequency of 5.3% in healthy Saudi adults which is at least 5 times higher than what has been reported from Western Europe and the United States. Seropositivity rate in the high-risk groups ranges from 15.9% in patients with STD to 78.6% in hemophiliacs. These data underscore the urgent need for routine anti-HCV screening of blood donations in order to reduce the frequency of postransfusion non-A, non-B hepatitis and its sequelae in the Saudi population.
PIP: Non-A, non-B hepatitis, recently renamed as hepatitis C virus (HCV), accounts for over 90% of hepatitis cases worldwide associated with blood transfusions. Application of a recombinant-based enzyme immunoassay for the detection of antibodies to HCV to a sample of 500 male Saudi blood donors and 260 healthy Saudi pregnant women indicated that HVC is endemic in the Saudi population. Anti-HCV was detected in 28 (5.6%) of the blood donors and 12 (4.6%) of the pregnant women, for an overall frequency of 5.3% in healthy Saudi adults who had never received blood transfusions. This rate is at least 5 times higher than that reported for the US and Western Europe. Also assessed was the HCV rate in subsamples of Saudis considered at risk of this infection. Here, anti-HCV was detected in 22 (78.6%) hemophiliacs, 26 (33.3%) patients with thalassemia and sickle cell disease, 17 (26.1%) hemodialysis patients with renal failure, and 35 (15.9%) individuals with a sexually transmitted disease. The prevalence of anti-HBc ranged from 28% in blood donors to 46% in hemophiliacs. The significantly higher prevalence of HCV in patients with sexually transmitted diseases than in blood donors suggests that this disease is transmitted through heterosexual contact as well as blood transfusions. Given the high baseline level of HCV infection in the Saudi population and the possibility of serious sequelae (e.g., chronic active hepatitis, cirrhosis, and hepatocellular carcinoma), routine anti-HCV screening of blood donations is urged.
Comment in
-
Hepatitis C antibody prevalence in Saudi Arabian blood donors.Vox Sang. 1991;61(4):279-80. doi: 10.1111/j.1423-0410.1991.tb00961.x. Vox Sang. 1991. PMID: 1776246 No abstract available.
Similar articles
-
Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.Mem Inst Oswaldo Cruz. 1993 Apr-Jun;88(2):305-7. doi: 10.1590/s0074-02761993000200021. Mem Inst Oswaldo Cruz. 1993. PMID: 7509022
-
Intrafamilial transmission of hepatitis C virus (HCV): a major mode of spread in the Saudi Arabia population.Ann Trop Paediatr. 1992;12(2):211-5. doi: 10.1080/02724936.1992.11747570. Ann Trop Paediatr. 1992. PMID: 1381898
-
Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics.Indian J Gastroenterol. 1992 Apr;11(2):80-1. Indian J Gastroenterol. 1992. PMID: 1428037
-
Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.FEMS Microbiol Rev. 1994 Jul;14(3):253-8. doi: 10.1111/j.1574-6976.1994.tb00096.x. FEMS Microbiol Rev. 1994. PMID: 7522023 Review.
-
Hepatitis C in dialysis units: the Saudi experience.Hemodial Int. 2007 Jul;11(3):354-67. doi: 10.1111/j.1542-4758.2007.00192.x. Hemodial Int. 2007. PMID: 17576302 Review.
Cited by
-
Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.World J Gastroenterol. 2014 Sep 28;20(36):12734-52. doi: 10.3748/wjg.v20.i36.12734. World J Gastroenterol. 2014. PMID: 25278675 Free PMC article. Review.
-
Decline in hepatitis B infection in sickle cell anaemia and beta thalassaemia major.Arch Dis Child. 1993 Nov;69(5):594-6. doi: 10.1136/adc.69.5.594. Arch Dis Child. 1993. PMID: 8257183 Free PMC article.
-
Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis.Hepat Mon. 2012 Apr;12(4):244-52. doi: 10.5812/hepatmon.844. Epub 2012 Apr 30. Hepat Mon. 2012. PMID: 22690231 Free PMC article.
-
Systematic overview of hepatitis C infection in the Middle East and North Africa.World J Gastroenterol. 2018 Jul 21;24(27):3038-3054. doi: 10.3748/wjg.v24.i27.3038. World J Gastroenterol. 2018. PMID: 30038471 Free PMC article.
-
Hepatobiliary Manifestations of Sickle Cell Anemia.Gastroenterology Res. 2010 Feb;3(1):1-8. doi: 10.4021/gr2010.01.1332. Epub 2010 Jan 20. Gastroenterology Res. 2010. PMID: 27956978 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials